Identity and synonyms
Catalog label is recorded; analytical identity and equivalence are not established.
Nonpeptide agent · Polysaccharide
Detailed molecular class: Nonpeptide agent; see mechanism for subtype
Supplied sequence or chemical reference
Mechanism
Glycosaminoglycan/polysaccharide, not a peptide; molecular weight and cross-linking change properties.
Evidence and critical reading
Reported scientific and empirical uses
Recovery and connective tissue · Skin, hair and cosmetics
Topical hydration, filler devices and joint products are distinct contexts.
Human evidence
Evidence must be tied to exact formulation, indication and route. An HA/multi-ingredient patch trial does not establish isolated catalog-HA benefit.
Preclinical evidence
Do not equate mechanism, cell culture or animal work with a clinical outcome. The specific level is detailed in the evidence assessment.
Critical reading and limitations
Evidence must be tied to exact formulation, indication and route. An HA/multi-ingredient patch trial does not establish isolated catalog-HA benefit.
Evidence must be tied to exact formulation, indication and route. An HA/multi-ingredient patch trial does not establish isolated catalog-HA benefit.
Source-specific regimens
Descriptive source observations, not individual recommendations.
Regulatory product labeling
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Human-study exposure
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Empirical handbook
No numerical human dose is assigned: reviewed sources did not verify a regimen attributable to this material, route and indication. Other molecules’ doses, animal exposures, vial amounts and dietary requirements are not substituted.
Regulation and safety
Jurisdiction-specific regulatory context
US: FDA-approved dermal-filler devices exist for specific products/indications. This is not generic hyaluronic-acid approval for any route/indication.
Adverse effects and unknowns
Filler risks include vascular occlusion; do not extrapolate cream tolerability to implanted/injected material.
Contraindications
A complete list must match the exact authorized product. For experimental materials without verified human labeling, a complete contraindication set is not established here. No list does not mean safety.
Interactions
Separate documented interaction, pharmacologic plausibility and unknown interaction. Absence of a blend trial does not establish compatibility.
Studies and trials
Selected studies
No selected studies are attributed in this record.
Trials attributed in the package
No trials are attributed in this record.
Trial registration does not establish efficacy or validate commercial material.
Query candidates; attribution pending
Hyaluronic acid · 1722 unfiltered query results, not authenticated trials
Query verification: October 16, 2026
Exact phrase intervention query; first three most recently updated records, not exhaustive. Aliases may be missed and heterogeneous products may appear. The total is the unfiltered registry query count, not authenticated trials. Source-integrity holds are excluded from ordinary listings.
View trial registry queryNCT06333782 · Evaluation of the Safety and Efficacy of Hyaluronic Acid Injection in Labia Majora AugmentationRegistry status: CompletedLast update posted: October 16, 2026Query verification: October 16, 2026
NCT07696364 · Chlorhexidine (CHX) Mouthwash With or Without an Anti-Discoloration System (ADS) During Experimental GingivitisRegistry status: CompletedLast update posted: October 16, 2026Query verification: October 16, 2026
NCT07468045 · Functional Outcomes After Hyaluronic Acid Injections Following ArthroscopyRegistry status: CompletedLast update posted: October 16, 2026Query verification: October 16, 2026
Source issues and references
References include queries and bibliographic handbook attributions; not all are clinical studies. Human review remains pending.
- REG-FILLERS
FDA: Dermal fillers, uses and risks
October 16, 2026
- SEARCH-PUBMED-hyaluronic-acid
October 16, 2026